DTC
Deep Track Capital Portfolio holdings
AUM
$3.11B
This Quarter Return
-1.07%
1 Year Return
+13.6%
3 Year Return
+265.73%
5 Year Return
–
10 Year Return
–
AUM
$2.67B
AUM Growth
+$2.67B
(-15%)
Cap. Flow
-$330M
Cap. Flow
% of AUM
-12.39%
Top 10 Holdings %
Top 10 Hldgs %
52.23%
Holding
84
New
14
Increased
17
Reduced
20
Closed
22
Top Buys
| 1 |
Cytokinetics
CYTK
|
$88M |
| 2 |
Dynavax Technologies
DVAX
|
$67.2M |
| 3 |
Harmony Biosciences
HRMY
|
$49.9M |
| 4 |
SEPN
Septerna, Inc. Common Stock
SEPN
|
$43.8M |
| 5 |
Structure Therapeutics
GPCR
|
$42.8M |
Top Sells
| 1 |
argenx
ARGX
|
$198M |
| 2 |
VRNA
Verona Pharma
VRNA
|
$108M |
| 3 |
Intellia Therapeutics
NTLA
|
$102M |
| 4 |
Alkermes
ALKS
|
$98M |
| 5 |
Axsome Therapeutics
AXSM
|
$77M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
76
Cassava Sciences
SAVA
$110M
| – | – | 0 | – | – |
|
|
SLN
77
Silence Therapeutics
SLN
$227M
| – | – | -1,000,000 | Closed | -$18.2M |
|
78
Scholar Rock
SRRK
$3.14B
| – | – | -48,100 | Closed | -$385K |
|
79
TG Therapeutics
TGTX
$4.65B
| – | – | -1,725,000 | Closed | -$40.3M |
|
80
Travere Therapeutics
TVTX
$1.56B
| – | – | -531,857 | Closed | -$7.44M |
|
|
VIGL
81
DELISTED
Vigil Neuroscience
VIGL
| – | – | -1,553,996 | Closed | -$5.28M |
|
82
Alto Neuroscience
ANRO
$99.6M
| – | – | -219,648 | Closed | -$2.51M |
|
83
Metagenomi
MGX
$65.3M
| – | – | -307,500 | Closed | -$667K |
|
|
SYRS
84
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| – | – | -828,485 | Closed | -$1.78M |
|